NASDAQ: IBRXImmunitybio Inc Stock Ownership - Who owns Immunitybio?
Insider buying vs selling
Have Immunitybio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Barry J. Simon | Director | 2026-10-05 | 25,000 | $10.75 | $268.75kSell |
| Cheryl Cohen | Director | 2026-10-02 | 55,979 | $2.98 | $166.82kBuy |
| Cheryl Cohen | Director | 2026-10-02 | 81,056 | $10.50 | $851.09kSell |
| Cheryl Cohen | Director | 2026-07-02 | 55,979 | $2.98 | $166.82kBuy |
| Cheryl Cohen | Director | 2026-07-02 | 131,210 | $9.50 | $1.25MSell |
| Christobel Selecky | Director | 2026-07-01 | 35,064 | $2.98 | $104.49kBuy |
| Christobel Selecky | Director | 2026-07-01 | 159,478 | $9.02 | $1.44MSell |
| Christobel Selecky | Director | 2026-07-01 | 124,414 | $2.99 | $372.00kBuy |
| Christobel Selecky | Director | 2026-06-30 | 1,000 | $9.00 | $9.00kSell |
| Christobel Selecky | Director | 2026-06-30 | 700 | $2.98 | $2.09kBuy |
IBRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IBRX insiders and whales buy or sell their stock.
IBRX Shareholders
What type of owners hold Immunitybio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Patrick Soonshiong | 6.64% | 70,341,055 | $730.14M | Insider |
| Barry J. Simon | 0.26% | 2,798,931 | $29.05M | Insider |
| Henry Ji | 0.07% | 776,535 | $8.06M | Insider |
| Richard Adcock | 0.05% | 562,274 | $5.84M | Insider |
| Richard Kusserow | 0.04% | 394,053 | $4.09M | Insider |
| David C. Sachs | 0.03% | 300,143 | $3.12M | Insider |
| Michael D. Blaszyk | 0.03% | 265,582 | $2.76M | Insider |
| John C. Thomas | 0.02% | 216,363 | $2.25M | Insider |
| John T. Potts Jr. | 0.02% | 159,253 | $1.65M | Insider |
| Regan J. Lauer | 0.01% | 115,875 | $1.20M | Insider |
IBRX vs Biotech Stocks
Immunitybio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.